<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38858642</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling.</ArticleTitle><Pagination><StartPage>555</StartPage><MedlinePgn>555</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">555</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-024-05355-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Astragaloside IV (AST-IV), as an effective active ingredient of Astragalus membranaceus (Fisch.) Bunge. It has been found that AST-IV inhibits the replication of dengue virus, hepatitis B virus, adenovirus, and coxsackievirus B3. Enterovirus 71 (EV71) serves as the main pathogen in severe hand-foot-mouth disease (HFMD), but there are no specific drugs available. In this study, we focus on investigating whether AST-IV can inhibit EV71 replication and explore the potential underlying mechanisms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The GES-1 or RD cells were infected with EV71, treated with AST-IV, or co-treated with both EV71 and AST-IV. The EV71 structural protein VP1 levels, the viral titers in the supernatant were measured using western blot and 50% tissue culture infective dose (TCID<sub>50</sub>), respectively. Network pharmacology was used to predict possible pathways and targets for AST-IV to inhibit EV71 replication. Additionally, ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) was used to investigate the potential targeted metabolites of AST-IV. Associations between metabolites and apparent indicators were performed via Spearman's algorithm.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study illustrated that AST-IV effectively inhibited EV71 replication. Network pharmacology suggested that AST-IV inhibits EV71 replication by targeting PI3K-AKT. Metabolomics results showed that AST-IV achieved these effects by elevating the levels of hypoxanthine, 2-ketobutyric acid, adenine, nicotinic acid mononucleotide, prostaglandin H2, 6-hydroxy-1 H-indole-3- acetamide, oxypurinol, while reducing the levels of PC (14:0/15:0). Furthermore, AST-IV also mitigated EV71-induced oxidative stress by reducing the levels of MDA, ROS, while increasing the activity of T-AOC, CAT, GSH-Px. The inhibition of EV71 replication was also observed when using the ROS inhibitor N-Acetylcysteine (NAC). Additionally, AST-IV exhibited the ability to activate the PI3K-AKT signaling pathway and suppress EV71-induced apoptosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests that AST-IV may activate the cAMP and the antioxidant stress response by targeting eight key metabolites, including hypoxanthine, 2-ketobutyric acid, adenine, nicotinic acid mononucleotide, prostaglandin H2, 6-Hydroxy-1 H-indole-3-acetamide, oxypurinol and PC (14:0/15:0). This activation can further stimulate the PI3K-AKT signaling to inhibit EV71-induced apoptosis and EV71 replication.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>JinFang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing Chronic Inflammation, Shanxi University of Chinese Medicine, Jinzhong, 030619, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8837-2770</Identifier><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China. 931326464@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ruixian</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Xiufeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qingshan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical, Department of Laboratory Medicine of Fenyang College, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China. sxlqs0501@sxtcm.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing Chronic Inflammation, Shanxi University of Chinese Medicine, Jinzhong, 030619, China. sxlqs0501@sxtcm.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan, China. sxlqs0501@sxtcm.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81301426</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>201901D111329</GrantID><Agency>the Provincial Natural Science Foundation of Shanxi</Agency><Country /></Grant><Grant><GrantID>202102130501005</GrantID><Agency>Key Research and Development Plan of Shanxi Province</Agency><Country /></Grant><Grant><GrantID>2020SHFZ38</GrantID><Agency>the Mega Research and Development Projects of Lüliang</Agency><Country /></Grant><Grant><GrantID>2020ZDSYS17</GrantID><Agency>the Key Laboratory Platform Construction Projects of Lüliang</Agency><Country /></Grant><Grant><GrantID>2023SHFZ50</GrantID><Agency>the Luliang City Social Development Key Research and Development Project</Agency><Country /></Grant><Grant><GrantID>2022C25</GrantID><Agency>the Shanxi Medical University Fenyang College Project</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012503">Saponins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014315">Triterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>3A592W8XKE</RegistryNumber><NameOfSubstance UI="C052064">astragaloside A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012503" MajorTopicYN="Y">Saponins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="Y">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014315" MajorTopicYN="Y">Triterpenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="Y">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091484" MajorTopicYN="Y">Network Pharmacology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Astragaloside IV</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword MajorTopicYN="N">Network pharmacology</Keyword><Keyword MajorTopicYN="N">Oxidative stress response</Keyword><Keyword MajorTopicYN="N">PI3K-AKT signaling</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>11</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>10</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38858642</ArticleId><ArticleId IdType="pmc">PMC11163744</ArticleId><ArticleId IdType="doi">10.1186/s12967-024-05355-9</ArticleId><ArticleId IdType="pii">10.1186/s12967-024-05355-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cui G, Wang H, Yang C, Zhou X, Wang J, Wang T, Ma T. Berberine prevents lethal EV71 neurological infection in newborn mice. Front Pharmacol. 2022;13:1027566. doi: 10.3389/fphar.2022.1027566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1027566</ArticleId><ArticleId IdType="pmc">PMC9640474</ArticleId><ArticleId IdType="pubmed">36386168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S, Tan SH, Ishiyama E, Ogasawara K, Hanasaka T, Ishida K, Hagiwara K, Liu CC, Chong PC, Hanaki KI, Schiavo G. The uncoating of EV71 in mature late endosomes requires CD-M6PR. Biol Open 2022, 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9493940</ArticleId><ArticleId IdType="pubmed">35929543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TTV, Le DN, Duong AH, Nguyen VL, Huynh TN, et al. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399:1708–17. doi: 10.1016/S0140-6736(22)00313-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00313-0</ArticleId><ArticleId IdType="pubmed">35427481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan X, Wu R, Kong XH, You Y, He K, Sun XY, Huang Y, Chen WX, Duan L. Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun (Lond) 2023;43:225–45. doi: 10.1002/cac2.12388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cac2.12388</ArticleId><ArticleId IdType="pmc">PMC9926958</ArticleId><ArticleId IdType="pubmed">36346061</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadaun P, Shah P, Harshithkumar R, Said MS, Bhoite SP, Bokuri S, Ravindran S, Mishra N, Mukherjee A. Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection. BMC Complement Med Ther. 2023;23:82. doi: 10.1186/s12906-023-03916-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-023-03916-x</ArticleId><ArticleId IdType="pmc">PMC10024014</ArticleId><ArticleId IdType="pubmed">36934258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q, Ye Z, Qin Y, Fan G, Ji S, Zhuo Q, Xu W, Liu W, Hu Q, Liu M, et al. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis. Oncogene. 2020;39:6572–88. doi: 10.1038/s41388-020-01452-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-020-01452-3</ArticleId><ArticleId IdType="pubmed">32929153</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, Hait A, Hernaez B, Knudsen A, Iversen MB, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Jia X, Zhang M, Cheng C, Liang X, Wang X, Xie F, Wang J, Yu Y, He Y, et al. Isoliquiritigenin inhibits virus replication and virus-mediated inflammation via NRF2 signaling. Phytomedicine. 2023;114:154786. doi: 10.1016/j.phymed.2023.154786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.154786</ArticleId><ArticleId IdType="pubmed">37002973</ArticleId></ArticleIdList></Reference><Reference><Citation>Long F, Zhang M, Yang X, Liang X, Su L, An T, Zhang G, Zeng Z, Liu Y, Chen W, Chen J. The Antimalaria Drug Artesunate inhibits Porcine Reproductive and Respiratory Syndrome Virus replication by activating AMPK and Nrf2/HO-1 signaling pathways. J Virol. 2022;96:e0148721. doi: 10.1128/JVI.01487-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01487-21</ArticleId><ArticleId IdType="pmc">PMC8826906</ArticleId><ArticleId IdType="pubmed">34787456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn EF, Connor JH. HijAkt: the PI3K/Akt pathway in virus replication and pathogenesis. Prog Mol Biol Transl Sci. 2012;106:223–50. doi: 10.1016/B978-0-12-396456-4.00002-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-396456-4.00002-X</ArticleId><ArticleId IdType="pmc">PMC7149925</ArticleId><ArticleId IdType="pubmed">22340720</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Li J, Wang PH, Yang N, Huang J, Ou J, Xu T, Zhao X, Liu T, Huang X, et al. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166260. doi: 10.1016/j.bbadis.2021.166260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166260</ArticleId><ArticleId IdType="pmc">PMC8390448</ArticleId><ArticleId IdType="pubmed">34461258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahon A, Arya RP, Banerjea AC. Dengue Virus Dysregulates Master transcription factors and PI3K/AKT/mTOR signaling pathway in Megakaryocytes. Front Cell Infect Microbiol. 2021;11:715208. doi: 10.3389/fcimb.2021.715208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.715208</ArticleId><ArticleId IdType="pmc">PMC8427595</ArticleId><ArticleId IdType="pubmed">34513730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Ming Y, Fu X, Niu Y, Lin Q, Liang H, Luo X, Liu L, Li N. PI3K/AKT/p53 pathway inhibits infectious spleen and kidney necrosis virus infection by regulating autophagy and immune responses. Fish Shellfish Immunol. 2022;120:648–57. doi: 10.1016/j.fsi.2021.12.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2021.12.046</ArticleId><ArticleId IdType="pubmed">34968710</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wu Y, Pei C, Wang M, Wang X, Shi S, Huang D, Wang Y, Li S, Xiao W, et al. Astragaloside IV pre-treatment attenuates PM2.5-induced lung injury in rats: impact on autophagy, apoptosis and inflammation. Phytomedicine. 2022;96:153912. doi: 10.1016/j.phymed.2021.153912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153912</ArticleId><ArticleId IdType="pubmed">35026504</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng BH, Zhou X, Wang Y, Chan JY, Lin HQ, Or PM, Wan DC, Leung PC, Fung KP, Wang YF, Lau CB. Herb-drug interaction between an anti-HIV Chinese herbal SH formula and atazanavir in vitro and in vivo. J Ethnopharmacol. 2015;162:369–76. doi: 10.1016/j.jep.2015.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2015.01.010</ArticleId><ArticleId IdType="pubmed">25614104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh YC, Doan LH, Huang ZY, Chu LW, Shi TH, Lee YR, Wu CT, Lin CH, Chiang ST, Liu HK, et al. Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in Vitro. Front Pharmacol. 2021;12:765553. doi: 10.3389/fphar.2021.765553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.765553</ArticleId><ArticleId IdType="pmc">PMC8990830</ArticleId><ArticleId IdType="pubmed">35401158</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JL, Xin M, Zhang LC. Protective effect of Astragalus membranaceus and astragaloside IV in sepsis-induced acute kidney injury. Aging. 2022;14:5855–77. doi: 10.18632/aging.204189.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.204189</ArticleId><ArticleId IdType="pmc">PMC9365550</ArticleId><ArticleId IdType="pubmed">35859295</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Zhou Z, Ai P, Zhang C, Chen J, Wang Y. Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway. Front Pharmacol. 2022;13:924826. doi: 10.3389/fphar.2022.924826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.924826</ArticleId><ArticleId IdType="pmc">PMC9437486</ArticleId><ArticleId IdType="pubmed">36059982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu H, Huang C, Cui X, Gao Y, Huang Y, Gong W, Zhao Y, Guo S. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. J Cardiovasc Pharmacol. 2006;47:190–5. doi: 10.1097/01.fjc.0000199683.43448.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.fjc.0000199683.43448.64</ArticleId><ArticleId IdType="pubmed">16495755</ArticleId></ArticleIdList></Reference><Reference><Citation>Indu P, Arunagirinathan N, Rameshkumar MR, Sangeetha K, Divyadarshini A, Rajarajan S. Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: computational docking and in vitro studies. Microb Pathog. 2021;152:104563. doi: 10.1016/j.micpath.2020.104563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104563</ArticleId><ArticleId IdType="pubmed">33098932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li J, Huang H, Gao W, Zhuang C, Li B, Zhou P, Kong D. Anti-hepatitis B virus activities of astragaloside IV isolated from radix astragali. Biol Pharm Bull. 2009;32:132–5. doi: 10.1248/bpb.32.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.32.132</ArticleId><ArticleId IdType="pubmed">19122295</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Qu Z, Sun L, Wang Y, Liu F, Wang S, Gao H, Jiang F. Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitro. J Pharm Pharmacol. 2011;63:688–94. doi: 10.1111/j.2042-7158.2011.01258.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2042-7158.2011.01258.x</ArticleId><ArticleId IdType="pubmed">21492171</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Yang F, Liu J, Zhang M, Sun J, Xiao Y, Xiao Z, Niu H, Ma R, Wang Y, et al. Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis. Exp Anim. 2019;68:549–58. doi: 10.1538/expanim.19-0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.19-0037</ArticleId><ArticleId IdType="pmc">PMC6842797</ArticleId><ArticleId IdType="pubmed">31243190</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Guo S, Li Y, Li J, Zhu L, Liu Y, Lv Y, Yu D, Zheng L, Huang C, et al. Berberine ameliorate inflammation and apoptosis via modulating PI3K/AKT/NFκB and MAPK pathway on dry eye. Phytomedicine. 2023;121:155081. doi: 10.1016/j.phymed.2023.155081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.155081</ArticleId><ArticleId IdType="pubmed">37748390</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Mathison BD, Hayek MG, Zhang J, Reinhart GA, Chew BP. Astaxanthin modulates age-associated mitochondrial dysfunction in healthy dogs. J Anim Sci. 2013;91:268–75. doi: 10.2527/jas.2012-5341.</Citation><ArticleIdList><ArticleId IdType="doi">10.2527/jas.2012-5341</ArticleId><ArticleId IdType="pubmed">23100599</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang ML, Chiang PS, Luo ST, Liou GY, Lee MS. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. J Virol Methods. 2010;165:42–5. doi: 10.1016/j.jviromet.2009.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.12.015</ArticleId><ArticleId IdType="pubmed">20036286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Hao J, Sun C, Du J, Han Q, Li Q. Total astragalosides decrease apoptosis and pyroptosis by inhibiting enterovirus 71 replication in gastric epithelial cells. Exp Ther Med. 2022;23:237. doi: 10.3892/etm.2022.11162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11162</ArticleId><ArticleId IdType="pmc">PMC8815049</ArticleId><ArticleId IdType="pubmed">35222714</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi: 10.1186/1752-0509-8-S4-S11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini FR, De Martino S, Fianco G, Ventura I, Valente D, Fiore M, Trisciuoglio D, Degrassi F. Blockage of autophagosome-lysosome fusion through SNAP29 O-GlcNAcylation promotes apoptosis via ROS production. Autophagy. 2023;19:2078–93. doi: 10.1080/15548627.2023.2170962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2023.2170962</ArticleId><ArticleId IdType="pmc">PMC10283446</ArticleId><ArticleId IdType="pubmed">36704963</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li Y, Wang X, Xie Y, Lou J, Yang Y, Jiang S, Ye M, Chen H, Diao W, Xu S. Pinocembrin alleviates pyroptosis and apoptosis through ROS elimination in random skin flaps via activation of SIRT3. Phytother Res. 2023;37:4059–75. doi: 10.1002/ptr.7864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7864</ArticleId><ArticleId IdType="pubmed">37150741</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu XQ, Xu T, Ji W, Wang C, Ren Y, Xiong X, Zhou X, Lin SH, Xu Y, Qiu Y. Herpes simplex virus 1-Induced Ferroptosis contributes to viral encephalitis. mBio. 2023;14:e0237022. doi: 10.1128/mbio.02370-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02370-22</ArticleId><ArticleId IdType="pmc">PMC9973258</ArticleId><ArticleId IdType="pubmed">36507835</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Liang Y, Ariffianto A, Matsui C, Abe T, Muramatsu M, Wakita T, Maki M, Shibata H, Shoji I, Hepatitis C, Virus-Induced ROS/JNK signaling pathway activates the E3 ubiquitin ligase itch to promote the release of HCV particles via polyubiquitylation of VPS4A. J Virol. 2022;96:e0181121. doi: 10.1128/jvi.01811-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01811-21</ArticleId><ArticleId IdType="pmc">PMC8941892</ArticleId><ArticleId IdType="pubmed">35044214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z, Yushanjiang F, Wang G, Zheng X, Jiang X. Germacrone mitigates cardiac remodeling by regulating PI3K/AKT-mediated oxidative stress, inflammation, and apoptosis. Int Immunopharmacol. 2023;124:110876. doi: 10.1016/j.intimp.2023.110876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.110876</ArticleId><ArticleId IdType="pubmed">37683399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 2005;78:82–90. doi: 10.1016/j.lfs.2005.04.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2005.04.076</ArticleId><ArticleId IdType="pmc">PMC7094582</ArticleId><ArticleId IdType="pubmed">16150462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Wu C, Wang Q, Deng D, Lin B, Hu X, Qiu F, Li Z, Huang C, Yang Q, Zhang D. Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71. Antiviral Res. 2023;211:105553. doi: 10.1016/j.antiviral.2023.105553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105553</ArticleId><ArticleId IdType="pubmed">36737007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Chen X, Shi Y, Zhou B, Du C, Liu Y, Han S, Yin J, Peng B, He X, Liu W. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes. 2014;49:373–82. doi: 10.1007/s11262-014-1114-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1114-4</ArticleId><ArticleId IdType="pubmed">25212431</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, Yin H, Liao L, Qin H, Ueda F, Uemura K, Eguchi K, Bharate GY, Maeda H. Water soluble PEG-conjugate of xanthine oxidase inhibitor, PEG-AHPP micelles, as a novel therapeutic for ROS related inflammatory bowel diseases. J Control Release. 2016;223:188–96. doi: 10.1016/j.jconrel.2015.12.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2015.12.049</ArticleId><ArticleId IdType="pubmed">26739550</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Iranzo FJ, López-Rodas AM, Franco L, López-Rodas G. Pentoxifylline and Oxypurinol: potential drugs to prevent the Cytokine Release (storm) syndrome caused by SARS-CoV-2? Curr Pharm Des. 2020;26:4515–21. doi: 10.2174/1381612826666200811180232.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612826666200811180232</ArticleId><ArticleId IdType="pubmed">32787748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Gao Y, Zhang C, Hu H, Guo D, Xu Y, Xu Q, Zhang W, Deng S, Lv P, et al. Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor against Hepatitis C Virus Infection. Sci Rep. 2017;7:5876. doi: 10.1038/s41598-017-06254-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06254-4</ArticleId><ArticleId IdType="pmc">PMC5517448</ArticleId><ArticleId IdType="pubmed">28724915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwilling M, Theiss C, Matschke V. Caffeine and NAD(+) improve motor neural Integrity of dissociated wobbler cells in Vitro. Antioxid (Basel) 2020, 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346375</ArticleId><ArticleId IdType="pubmed">32471290</ArticleId></ArticleIdList></Reference><Reference><Citation>Enkhtaivan G, Muthuraman P, Kim DH. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection. J Mol Recognit 2017, 30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28233349</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang K, Wu H, Liu Y, Wang S, Li X, Yang B, Zhang Y, Ma L, Lu G, He L, et al. MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial injury. Theranostics. 2023;13:2721–33. doi: 10.7150/thno.83543.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.83543</ArticleId><ArticleId IdType="pmc">PMC10196836</ArticleId><ArticleId IdType="pubmed">37215581</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo J, Bellot G, Pervaiz S, Alonso S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 2022;30:679–92. doi: 10.1016/j.tim.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.12.011</ArticleId><ArticleId IdType="pubmed">35063304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullberg RC, Jordan Steel J, Moon SL, Soltani E, Geiss BJ. Oxidative stress influences positive strand RNA virus genome synthesis and capping. Virology. 2015;475:219–29. doi: 10.1016/j.virol.2014.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.10.037</ArticleId><ArticleId IdType="pmc">PMC4332586</ArticleId><ArticleId IdType="pubmed">25514423</ArticleId></ArticleIdList></Reference><Reference><Citation>Miripour ZS, Sarrami-Forooshani R, Sanati H, Makarem J, Taheri MS, Shojaeian F, Eskafi AH, Abbasvandi F, Namdar N, Ghafari H, et al. Real-time diagnosis of reactive oxygen species (ROS) in fresh sputum by electrochemical tracing; correlation between COVID-19 and viral-induced ROS in lung/respiratory epithelium during this pandemic. Biosens Bioelectron. 2020;165:112435. doi: 10.1016/j.bios.2020.112435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2020.112435</ArticleId><ArticleId IdType="pmc">PMC7341050</ArticleId><ArticleId IdType="pubmed">32729548</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas FH, Shehata M, Elgaher WAM, Lacour A, Kurmasheva N, Begnini F, Kiib AE, Dahlmann J, Chen C, Pavlou A, et al. NRF2 activators inhibit influenza a virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathog. 2023;19:e1011506. doi: 10.1371/journal.ppat.1011506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011506</ArticleId><ArticleId IdType="pmc">PMC10374058</ArticleId><ArticleId IdType="pubmed">37459366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ML, Weng SF, Kuo CH, Ho HY. Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication. PLoS ONE. 2014;9:e113234. doi: 10.1371/journal.pone.0113234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113234</ArticleId><ArticleId IdType="pmc">PMC4234665</ArticleId><ArticleId IdType="pubmed">25401329</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair V, Ussery MA. New hypoxanthine nucleosides with RNA antiviral activity. Antiviral Res. 1992;19:173–8. doi: 10.1016/0166-3542(92)90076-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(92)90076-H</ArticleId><ArticleId IdType="pubmed">1444325</ArticleId></ArticleIdList></Reference><Reference><Citation>Altan-Bonnet N. Lipid tales of viral replication and transmission. Trends Cell Biol. 2017;27:201–13. doi: 10.1016/j.tcb.2016.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.09.011</ArticleId><ArticleId IdType="pmc">PMC5318230</ArticleId><ArticleId IdType="pubmed">27838086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SU, Oyeyemi BF, Shet A, Gopalan BP, Bhavesh DH, Tandon NS. Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy. PLoS ONE. 2020;15:e0238316. doi: 10.1371/journal.pone.0238316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238316</ArticleId><ArticleId IdType="pmc">PMC7458310</ArticleId><ArticleId IdType="pubmed">32866201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol. 2002;215:61–71. doi: 10.1016/S0008-8749(02)00017-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-8749(02)00017-5</ArticleId><ArticleId IdType="pubmed">12142037</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang X, Wu Q, Wang H, Zhao L, Wang X, Mu M, Xie E, He X, Shao D, et al. Adenine alleviates iron overload by cAMP/PKA mediated hepatic hepcidin in mice. J Cell Physiol. 2018;233:7268–78. doi: 10.1002/jcp.26559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26559</ArticleId><ArticleId IdType="pmc">PMC7754534</ArticleId><ArticleId IdType="pubmed">29600572</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu Y, Meng X, Wang Z, Younis M, Liu Y, Wang P, Huang X. SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ. 2022;29:1395–408. doi: 10.1038/s41418-022-00928-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00928-x</ArticleId><ArticleId IdType="pmc">PMC8752586</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundhra S, Bondre VP. Higher replication potential of West Nile virus governs apoptosis induction in human neuroblastoma cells. Apoptosis. 2023;28:1113–27. doi: 10.1007/s10495-023-01844-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-023-01844-2</ArticleId><ArticleId IdType="pubmed">37186273</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JJ, Liu ML, Lv JN, Chen RL, Ding K, He JQ. Polysaccharides from Platycodonis Radix ameliorated respiratory syncytial virus-induced epithelial cell apoptosis and inflammation through activation of miR-181a-mediated Hippo and SIRT1 pathways. Int Immunopharmacol. 2022;104:108510. doi: 10.1016/j.intimp.2021.108510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108510</ArticleId><ArticleId IdType="pubmed">34999393</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannello A, Debbeche O, Martin E, Attalah LH, Samarani S, Ahmad A. Viral strategies for evading antiviral cellular immune responses of the host. J Leukoc Biol. 2006;79:16–35. doi: 10.1189/jlb.0705397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0705397</ArticleId><ArticleId IdType="pubmed">16204622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong H, Du N, Yang Y, Song L, Zhang W, Tien P. Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax. J Virol. 2016;90:9862–77. doi: 10.1128/JVI.01499-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01499-16</ArticleId><ArticleId IdType="pmc">PMC5068536</ArticleId><ArticleId IdType="pubmed">27558414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ampomah PB, Lim LHK. Influenza a virus-induced apoptosis and virus propagation. Apoptosis. 2020;25:1–11. doi: 10.1007/s10495-019-01575-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-019-01575-3</ArticleId><ArticleId IdType="pubmed">31667646</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Guo H, Zhang X, Yang Z, Ruganzu JB, Yang Z, Wu X, Bi W, Ji S, Yang W. TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K/Akt/GSK-3β signaling pathway in vivo and in vitro. Mol Neurobiol. 2023;60:2470–85. doi: 10.1007/s12035-023-03217-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-023-03217-x</ArticleId><ArticleId IdType="pubmed">36662361</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Zhang X, Wu H, Liu C, Li Z, Hu X, Su S, Wang LF, Qu L. Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes. Front Microbiol. 2015;6:886. doi: 10.3389/fmicb.2015.00886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.00886</ArticleId><ArticleId IdType="pmc">PMC4557281</ArticleId><ArticleId IdType="pubmed">26388843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Duan J, Liao J, Wang Y, Xiao X, Li L, Liu Y, Gu H, Yang P, Fu D, et al. LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis. Aging. 2022;14:6809–28. doi: 10.18632/aging.204256.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.204256</ArticleId><ArticleId IdType="pmc">PMC9467416</ArticleId><ArticleId IdType="pubmed">36044268</ArticleId></ArticleIdList></Reference><Reference><Citation>Farid HA, Sayed RH, El-Shamarka ME, Abdel-Salam OME, El Sayed NS. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats. Inflammopharmacology 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11006765</ArticleId><ArticleId IdType="pubmed">37541971</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhang X, Che D, Zeng L, Zhang Y, Nan K, Zhang X, Zhang H, Guo Z. 6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K/AKT/mTOR signaling pathway. Phytother Res. 2023;37:124–39. doi: 10.1002/ptr.7601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7601</ArticleId><ArticleId IdType="pubmed">36116140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Cong H, Song L, Tien P. The nuclear protein Sam68 is redistributed to the cytoplasm and is involved in PI3K/Akt activation during EV71 infection. Virus Res. 2014;180:1–11. doi: 10.1016/j.virusres.2013.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.11.020</ArticleId><ArticleId IdType="pubmed">24316008</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>